Tocilizumab reduces hypercoagulation in COVID-19 – Perspectives from the coagulation and immunomodulation Covid assessment (Coag-ImmCovA) clinical trial
Tocilizumab reduces hypercoagulation in COVID-19 – Perspectives from the coagulation…
Ler MaisTocilizumab reduces hypercoagulation in COVID-19 – Perspectives from the coagulation…
Ler MaisHeat stress–induced platelet dysfunction is associated with loss of fibrinogen…
Ler MaisInterventional Algorithm in Gastrointestinal Bleeding—An Expert Consensus Multimodal Approach Based…
Ler MaisInterventional Algorithms for the Control of Coagulopathic Bleeding in Surgical,…
Ler Mais